Microemulsions: A novel approach to enhanced drug delivery

Recent Patents on Drug Delivery and Formulation

Volumn 2, Issue 3, 2008, Pages 238-257

  Talegaonkar, Sushama ^a   Azeem, Adnan ^a   Ahmad, Farhan J ^a   Khar, Roop K ^a   Pathan, Shadab A ^a   Khan, Zeenat I ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bioavailability; Microemulsion; Microemulsion preconcentrate; Poorly soluble drugs; Self microemulsifying; Sustained and targeted drug delivery; Thermodynamically stable

Indexed keywords

ATORVASTATIN; CASTOR OIL; CYCLOSPORIN; CYCLOSPORIN A; DECANOIC ACID; DIETHYLENE GLYCOL MONOETHYL ETHER; ETHYLENE OXIDE; FELODIPINE; FENOFIBRATE; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; LABRASOL; LAURIC ACID; LINOLEIC ACID; LINOLENIC ACID; METHYLCELLULOSE; MIGLYOL; MYRISTIC ACID; OCTANOIN; OLEIC ACID; PACLITAXEL; POLOXAMER; RAPAMYCIN; RITONAVIR; SAQUINAVIR; SURFACTANT; UNINDEXED DRUG; WATER OIL CREAM;

BIOCOMPATIBILITY; CANCER CELL; CHEMICAL STRUCTURE; CONTROLLED RELEASE FORMULATION; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; LIGHT SCATTERING; LIPOPHILICITY; MEDICAL RESEARCH; MICROEMULSION; NEUTRON SCATTERING; OXIDATION; PARTICLE SIZE; PATENT; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RADIATION SCATTERING; REVIEW; SOLUBILIZATION; SUSTAINED RELEASE FORMULATION; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY;

EID: 58049193000     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221108786241679     Document Type: Review

References (189)

1. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993; 82: 979-986.
2. Serajuddin ATM. Solid dispersion of poorly water soluble drugs: early promises, subsequent problems and recent breakthroughs. J Pharm Sci 1999; 88: 1058-1066.
3. Robinson JR. Introduction: Semi-soild formulations for oral drug delivery. B T Gattefosse 1996; 89: 11-13.
4. Kang BK, Chon SK, Kim SH, et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of antitumour activity in vitro and in vivo. Int J Pharm 2004; 286: 147-156.
5. Burcham DL, Maurin MB, Hausner, EA, Huang SM. Improved oral bioavailability of the hypocholesteromic DMP 565 in dogs following oral dosing in oil and glycol solutions. Biopharm Drug Dispos 1997; 18: 737-742.
6. Schwendener RA, Schott H. Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. J Cancer Res Clin Oncol 1996; 122: 723-726.
7. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Selfemulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106: 15-23.
8. Aungst BJ, Nguyen N, Rogers NJ, et al. Improved oral bioavailability of an HIV protease inhibitor using Gelucire 44/14 and labrasol vehicles. B.T. Gattefosse 1994; 87: 49-54.
9. Myers RA, Stella VJ. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm 1992; 78: 217-226.
10. Kararli TT, Needham TE, Griffin M, Schoenhard G, Ferro LJ, Alcorn L. Oral delivery of a renin inhibitor compound using emulsion formulations. Pharm Res 1992; 9: 888-893.
11. Chasmar WN, Stella WJ (ed.), Lipid vehicle and formulation effects on intestinal lymphatic drug transport; In: Lymphatic transport of drugs. Boca Raton, FL, CRC Press 1992; 113-179.
12. Serajuddin ATM, Shee PC, Mufson D, Bernstein DF, Augustine MA. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water soluble drug from solid dispersion. J Pharm Sci 1988; 77: 414-417.
13. Palin KJ, Phillips AJ, Ning A. The oral absorption of cefoxitin from oil and emulsion vehicles in rats. Int J Pharm 1986; 33: 99-104.
14. Stella VJ, Haslam J, Yata N, Okada H, Lindenbaum S, Higuchi T. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J Pharm Sci 1978; 67: 1375-1377.
15. Kovarik JM, Mueller EA, van Bree JB, Tetzloff W, Kutz, K. Reduced inter and intra intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994; 83: 444-446.
16. Noble S, Markham A. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion based formulation (Neoral®). Drugs 1995; 50: 924-941.
17. Erkko P, Granlund H, Nuutinen M, Reitamo S. Comparison of cyclosporine A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis. Br J Dermatol 1997; 136: 82-88.
18. Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surfaces B: Biointerfaces 2005; 41: 25-32.
19. Elena P, Paola S, Maria RG. Transdermal permeation of apomorphine through hairless mouse skin from microemulsions. Int J Pharm 2001; 226: 47-51.
20. Biruss B, Kahlig H, Valenta C. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. Int J Pharm 2007; 328: 142-151.
21. Rhee Y-S, Choi, J-G, Park E-S, Chi S-C. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm 2001; 228: 161-170.
22. Yuan Y, Li S-M, Mo F-K, Zhong D-F. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm 2006; 321: 117-123.
23. Bowman, L.M., Patel, R.A., Ottoboni, T.B.: US5977171 (1999).
24. Lianly IL, Nandi I, Kim KH. Development of an ethyl laurate based microemulsion for rapid onset of intranasal delivery of diazepam. Int J Pharm 2002; 237: 77-85.
25. Vyas TK, Babbar AK, Sharma RK, Singh S, Misra, A. Intranasal mucoadhesive microemulsions of clonazepam: Preliminary studies on brain targeting. J Pharm Sci 2005; 95: 570-580.
26. Sommerville ML, Cain JB, Johnson Jr. CS, Hickey AJ. Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants. Pharm Dev Technol 2000; 5: 219-230.
27. D'Cruz OJ, Yiv SH, Uckun FM. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion. AAPS Pharm Sci Tech 2001; 2: E5.
28. D'Cruz OJ, Uckun FM. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception 2001; 64: 113-123.
29. Cho, Y.W., Flynn, M.J.: US5656289 (1997).
30. Cho, Y.W., Flynn, M.J., Shepherd, T.S.: US5665700 (1998).
31. von Corswant C, Thoren P, Engstrom S. Triglyceride based microemulsion for intravenous administration of sparingly soluble substances. J Pharm Sci 1998; 87: 200-208.
32. Schulman JH, Stoeckenius W, Prince LM. Mechanism of formation and structure of microemulsions by electron microscopy. J Phys Chem 1959; 63: 1677-1680.
33. Holm R, Porter CJH, Edward GA, Mullertz, A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self- microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003; 20: 91-97.
34. Pouton CW. Lipid formulation for oral administration of drugs: non- emulsifying, self- emulsifying and self- microemulsifying drug delivery systems. Eur J Pharm Sci 2000; 11: S93-S98.
35. Pouton CW. Formulation of self-microemulsifying delivery system. Adv Drug Del Rev 1997; 25: 47-58.
36. Lam AC, Schechter RS. The theory of diffusion in microemulsions. J Colloid Interface Sci 1987; 120: 56-63.
37. Hellweg T. Phase structure of microemulsions. Curr Opin Colloid Interface Sci 2002; 7: 50-56.
38. Ghosh PK, Murthy RSR. Microemulsions: A potential drug delivery system. Curr Drug Deliv 2006; 3: 167-180.
39. Bhargava HN, Narurkar A, Lieb LM. Using microemulsions for drug delivery. Pharm Tech 1987; 11: 46-52.
40. Kreuter J. Microemulsions; In: Colloidal drug delivery systems. New York: Marcel Dekker 1994; 31-71.
41. Lawrence M.J. Surfactant systems: microemulsions and vesicles as vehicles for drug delivery. Eur J Drug Metab Pharmacokinet 1994; 3: 257-269.
42. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Therapeut Drug Carrier Syst 1999; 16: 461-521.
43. Lawrence MJ, Rees GD. Microemulsion based media as novel drug delivery systems. Adv Drug Del Rev 2000; 47: 89-121.
44. Aboofazeli R, Lawrence CB, Wicks SR, Lawrence MJ. Investigations into the formation and characterization of phospholipid microemulsions III. Pseudo-ternary phase diagrams of systems containing water-lecithin-isopropyl myristate and either an alkanoic acid, amine, alkanediol, poly ethylene glycol alkyl ether or alcohol as co-surfactant. Int J Pharm 1994; 111: 63-72.
45. Stilbs P, Lindman B, Rapacki K. Effect of alcohol cosurfactant length on microemulsion structure. J Colloid Interface Sci 1983; 95: 583-585.
46. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. Formulation development and optimization using nanoemulsion technique: A technical note. AAPS Pharm Sci Tech 2007; 8(2): E1-E6.
47. Constantinides PP, Yiv SH. Particle size determination of phaseinverted water-in-oil microemulsions under different dilution and storage conditions. Int J Pharm 1995; 115: 225-234.
48. Mueller BW, Mueller RH. Particle size distributions and particle size alterations in microemulsions. J Pharm Sci 1984; 73: 919-922.
49. Porras M, Solans C, Gonzalez, C, Martinez A, Guinart A, Gutierrez, JM. Studies of formation of w/o nanoemulsions. Colloid Surf A: Physicochem Eng Asp 2004; 249: 115-118.
50. Burnett GR, Rees GD, Steytler DC, Robinson BH. Fluorescence correlation spectroscopy of water-in-oil microemulsions: an application in specific characterization of droplets containing biomolecules. Colloids Surf A: Physicochem Eng Asp 2004; 250: 171-178.
51. Silas JA, Kaler EW. Effect of multiple scattering on SANS spectra from bicontinuous microemulsions. J Colloid Interface Sci 2003; 257: 291-298.
52. Pedersen JS. Analysis of small-angle scattering data from micelles and microemulsions: Free-form approaches and model fitting. Curr Opin Colloid Interface Sci 1999; 4: 190-196.
53. Podlogar F, Gasperlin M, Tomsic M, Jamnik A, Bester Rogac M. Structural characterisation of water-Tween 40®/Inwitor 308®-isopropylmyristate microemulsions usinf different experimental methods. Int J Pharm 2004; 276: 115-128.
54. Kawakami K, Yoshikawa T, Moroto Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs: I. Prescription design. J Control Release 2002; 81: 65-74.
55. Glatter O, Orthaber D, Stradner A, et al. Sugar-ester nonionic microemulsion: Structural characterization. J Colloid Interface Sci 2001; 241: 215-225.
56. Kumar P, Mittal KL. Microemulsions in foods; In: Handbook of Microemulsion Science and Technology. New York, Marcel Dekker 1999; 789.
57. Solans C, Kuneida H. Microemulsions in the pharmaceutical field: perspectives and applications; In: Industrial Applications of Microemulsions. New York, Marcel Dekker 1997; 98-120.
58. Solans C, Kuneida H. (ed.), Microemulsions in foods: Properties and applications; In: Industrial applications of microemulsions. New York, Marcel Dekker, 1997; 148.
59. Danino D, Gupta R, Satyavolu J, Talmon Y. Direct Cryogenictemperature transmission electron microscopy imaging of phospholipids aggregates in soybean oil. J Colloid Interface Sci 2002; 249: 180-186.
60. Danino D, Talmon Y, Zana R. Cryo-TEM of thread like micelles: on the grid microstructural transformations induced during specimen preparation Colloid Surf A: Physicochem Eng Asp 2002; 169: 67-73.
61. Jian X, Ganzuo L, Zhiqiang Z, Guowei Z, Kejian J. A study of the microstructure of CTAB/1-butanol/octane/water system by PGSENMR, conductivity and cryo-TEM. J Colloid Surf A: Physicochem Eng Asp 2001; 191: 269-278.
62. Magdassi S, Ben Moshe M, Talmon Y, Danino D. Microemulsion based on anionic Gemini surfactant. Colloid Surf A: Physicochem Eng Asp 2003; 212: 1-7.
63. Andersson M, Lofroth J-E. Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion. Int J Pharm 2003; 257: 305-309.
64. Kreilgaard M, Pedersen EJ, Jaroszewski JW. NMR characterization and transdermal drug delivery potential microemulsion systems. J Control Release 2000; 69: 421-433.
65. Lopez F, Cinelli G, Ambrosone L, Colafemmina G, Ceglie A, Palazzo G. Role of the cosurfactant in water-in-oil microemulsion: interfacial properties tune the enzymatic activity of lipase. Colloid Surf A: Physicochem Eng Asp 2004; 237: 49-59.
66. 10/oil/water system. Colloid Surf A: Physicochem Eng Asp 2003; 216: 55-63.
67. Fanun M, Wachtel E, Antalek B, Aserin A, Hoffman RE, Garti N. A study of the microstructure of four-component sucrose ester microemulsions by SAXS and NMR. Colloid Surf A: Physicochem Eng Asp 2001; 180: 173-186.
68. Djordjevic L, Primorac M, Stupar M, Krajisnik D. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int J Pharm 2004; 271: 11-19.
69. Mrestani Y, El-Mokdad N, Ruttinger HH, Neubert RHH. Characterization of partitioning behaviour of cephalosporins using microemulsion and micellar electrokinetic chromatography. Electrophoresis 1998; 19: 2895-2899.
70. Mrestani Y, Neubert RHH, Krause A. Partition behaviour of drugs in microemulsions measured by electrokinetic chromatography. Pharm Res 1998; 15: 799-801.
71. Moulik SP, Paul BK. Structure, dynamics and transport properties of microemulsions. Adv Colloid Interface Sci 1998; 78: 99-195.
72. Raimar LE, Gordon LA. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000; 50: 3-12.
73. Sariciaux MJ, Alan L, Sado PA. Using microemulsion for drug delivery of therapeutic peptides. Int J Pharm 1995; 12: 127-136.
74. Swenson EC, Curatolo WJ. Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanism and potential toxicity. Adv Drug Del Rev 1992; 8: 39-42.
75. Gao, P., Morozowich, W.: US20067115565 (2006).
76. Farah, N., Denis, J.: US20006054136 (2000).
77. Farah, N., Denis, J.: US20016312704 (2001).
78. Fricker, G., Haeberlin, B., Meinzer, A., Vonderscher, J.: US20067025975 (2006).
79. Fricker, G., Haeberlin, B., Meinzer, A., Vonderscher, J.: US5932243 (1999).
80. Liang, L., Shojaei, A.H., Ibrahim, S.A., Burnside, B.A.: US20067022337 (2006).
81. Stamm, A., Seth, P.: US20016277405 (2001).
82. Stamm, A., Seth, P.: US20006074670 (2000).
83. Curtet, B., Teillaud, E., Reginault, P.: US4895726 (1990).
84. Boyer, J.F.: US4800079 (1989).
85. Laruelle, C.: US5827536 (1998).
86. Gumkowski, M.J., Franco, L., Murdande, S.B., Perlman, M.E.: US20056962931 (2005).
87. Lambert, K.J., Constantinides, P.P., Quay, S.C.: US20036667048 (2003).
88. Lambert, K.J., Constantinides, P.P., Tustian, A.K., Quay, S.C.: US20036660286 (2003).
89. Benameur, H., Jannin, V., Roulot, D.: US20036652865 (2003).
90. von Corswant, C.: US20036602511 (2003).
91. Chen, S., Gunn, J.A.: US20036555558 (2003).
92. Gao, P., Morozowich, W.: US20036531139 (2003).
93. Gao, P., Morozowich, W.: US20006121313 (2000).
94. Gao, P., Morozowich, W.: US20016231887 (2001).
95. Bauer, K., Neuber, C., Schmid, A., Volker, K.M.: US20026426078 (2002).
96. Mishra, A., Moussa, I., Ramtoola, Z., Clarke, N.: US20016284268 (2001).
97. Ward, M.V., Cotter, R.: US4678808 (1987).
98. Crison, J.R., Amidon, G.L.: US5993858 (1999).
99. Burnside, B.A., Mattes, C.E., McGuinness, C.M., Rudnic, E.M., Belendiuk, G.W.: US5883103 (1999).
100. Rudnic, E., McCarty, J., Burnside, B., McGuinness, C., Belenduik, G.: US5952004 (1999).
101. Graziella, B.: US5362745 (1994).
102. Eugster, C., Eugster, C.H., Haldemann, W., Rivara, G.: US5496813 (1996).
103. Ecanow, B.: US4963367 (1990).
104. Dong, L.-C., Espinal, S., Wong, P.S.L.: US20067147867 (2006).
105. Barthelemy, P., Benameur, H.: US20016309665 (2001).
106. Dong, L.-C., Espinal, S., Wong, P.S.L.: US20016174547 (2001).
107. Bansal T, Mustafa G, Khan ZI, Ahmad FJ, Khar RK, Talegaonkar S. Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit Rev Ther Drug Carrier Syst 2008; 25: 63-116.
108. Pather, S.I., Gupte, S.V., Khankari, R.K., Hontz, J., Robinson, J.R., Eichman, J.D., Kumbale, R.: US20016280770 (2001).
109. Mulye, N.: US20026436430 (2002).
110. Cleland JL, Daugherty A, Mrysny R. Emerging protein delivery methods. Curr Opin Biotech 2001; 12: 212-219.
111. Burnside, B.A., Mattes, C.E., McGuinness, C.M., Rudnic, E.M., Belendiuk, G.W.: US5824638 (1998).
112. Cho, Y.W., Lee, K.-H.: US20056951655 (2005).
113. Owen, A.J., Yiv, S.H.: US5646109 (1997).
114. Owen, A.J., Yiv, S.H., Sarkahian, AB.: US5688761 (1997).
115. Desai, A. J.: US5206219 (1993).
116. Poli, S., Mailland, F., Moro, L.: US5759566 (1998).
117. Ekwuribe, N.N., Ramaswamy, M., Radhakrishnan, B., Allaudeen, H.S.S.: US20016191105 (2001).
118. Cavanak, T.: US4388307 (1983).
119. Hauer, B., Meinzer, A., Posanski, U., Richter, F.: US5342625 (1994).
120. Hauer, B., Meinzer, A., Posanski, U., Richter, F.: US20077235248 (2007).
121. Hauer, B., Meinzer, A., Posanski, U., Vonderscher, J.: US20056844459 (2005).
122. Hauer, B., Meinzer, A., Posanski, U., Vonderscher, J.: US20016262022 (2001).
123. Hauer, B., Meinzer, A., Posanski, U., Richter, F.: US5962017 (1999).
124. Hauer, B., Meinzer, A., Posanski, U., Richter, F.: US6007840 (1999).
125. Hauer, B., Meinzer, A., Posanski, U., Richter, F.: US5866159 (1999).
126. Cottens, S., Haeberlin, B., Sedrani, R., Vonderscher, J.: US20077205279 (2007).
127. Ambuhl, M., Luckel, B., Haberlin, B., Meinzer, A.: US20046767555 (2004).
128. Mulye, N.: US20006057289 (2000).
129. Bhalani, V.T., Patel, S.P.: US5858401 (1999).
130. Bhalani, V.T., Patel, S.P.: US20067070802 (2006).
131. Naicker S.A., Yatscoff, R.W., Foster, R.T.: US20067060672 (2006).
132. Chakravorty, S., Bharti, P.: US20067056530 (2006).
133. Domb, A.J.: US20067026290 (2006).
134. Egbaria, K.F., Groves, M.J.: US20056960563 (2005).
135. Meinzer, A., Haeberlin, B.: US20046723339 (2004).
136. Meinzer, A., Haeberlin, B.: US20026475519 (2002).
137. Stuchlik, M., Andrysek, T., Jegorov, A., Husek, A., Matha, V., Stuchlik, J., Benesova, K.: US20016312721 (2001).
138. Singh, A., Jain, R.: US20016187747 (2001).
139. Singh, A., Jain, R.: US20026346511 (2002).
140. Hong, C II., Kim, J.W., Choi, N.H., Shin, H.J., Yang, S.G., Kim, J.H., Lim, J.L., Kim, C.K.: US20016306434 (2001).
141. Hong, C II., Kim, J.W., Choi, N.H., Shin, H.J., Yang, S.G.: US20006028067 (2000).
142. Sherman, B.C.: US20016258783 (2001)
143. Sherman, B.C.: US5998365 (1999).
144. Sherman, B.C.: US20006159933 (2000).
145. Kim, J.W., Shin, H.J., Yang, S.G.: US5980939 (1999).
146. Woo, J.S.: US5639474 (1997).
147. Woo, J.S.: US5603951 (1997).
148. Woo, J.S.: US5589455 (1996).
149. Shaw JM. In: Lipoproteins as carriers of pharmacological agents. Marcel Dekker, New York 1991; 97-139.
150. Kyung-Mi P, Chong-Kook K. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int J Pharm 1999; 181: 173-179.
151. Lee J-M, Park K-M, Lim S-J, Lee M-K, Kim C-K. Microemlsion formulation of clonixic acid: solubility enhancement and pain reduction. J Pharm Pharmacol 2002; 54: 43-49.
152. Rhee YS, Park CW, Nam, TY, Shin YS, Chic SC, Park ES. Formulation of parenteral microemulsion containing itraconazole. Arch Pharm Res 2007; 30: 114-123.
153. Ryoo HK, Park CW, Chi SC, Park ES. Development of propofol loaded microemulsion systems for parenteral delivery. Arch Pharm Res 2005; 28: 1400-1404.
154. Hwang SR, Lim SJ, Park JS, Kim CK. Phospholipid based microemulsion formulation for all-trans-retinoic acid for parenteral administration. Int J Pharm 2004; 276: 175-183.
155. Zhao X, Chen D, Gao P, Ding P, Li K. Synthesis of Ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery. Chem Pharm Bull 2005; 53: 1246-1250.
156. Jumma M, Muller BW. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharm 1998; 163: 81-89.
157. Dennis, D.M., Gravenstein, N., Modell, J.H., Morey, T.E., Shah, D.: US20036623765 (2003).
158. Dennis D.M., Gravenstein, N., Modell, J.H., Morey, T.E., Shah, D.: US20036638537 (2003).
159. Yiv, S.H., Tustian, A.K.: US20016245349 (2001).
160. Wretlind, K.A.J., Ljungberg, S., Hakansson, I., Ajaxon, B.M.: USRE32393 (1987).
161. Autuori, F., Bianchini, C., Bottoni, G., Leoni, F., Mascagni, P., Piccolo, O.: US20077157099 (2007).
162. Sadek, S.E.: US3976071 (1976).
163. Vigne, J.-L., Kane, J.P.: US5023271 (1991).
164. Kriwet K, Muller-Goymann CC. Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int J Pharm 1995; 125: 231-242.
165. Trotta M. Influence of phase transformation on indomethacin release from microemulsions. J Control Rel 1999; 60: 399-405.
166. Schmalfuβ U, Neubert R, Wohlrab W. Modification of drug penetration into human skin using microemulsions. J Control Rel 1997; 46: 279-285.
167. Changez M, Varshney M., Chander J, Dinda AK. Effect of the composition of lecithin/n-propanol/isopropylmyristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Colloids Surf B: Biointerfaces 2006; 50: 18-25.
168. Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001; 215: 57-65.
169. Trotta M, Morel S, Gasco MR. Effect of oil phase composition on the skin permeation of felodipine from w/o microemulsions. Pharmazie 1997; 52: 50-53.
170. Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 2004; 98: 427-436.
171. Hua L, Weisan P, Jiayu L, Ying Z. Preparation, evaluation and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev Ind Pharm 2004; 30: 657-666.
172. Kreilgaard M. Influence of microemulsion on cutaneous drug delivery. Adv Drug Delivery Rev 2002; 54: S77-S98.
173. Mohammed C, Manoj V. Aerosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride. Drug Dev Ind Pharm 2000; 26: 507-572.
174. Muller, B.W.W., Franzky, H.-J., Kolln, C.-J.: US4719239 (1988).
175. Protopapa, E., Xenakis, A., Avramiotis, S., Sekeris, K.: US20016203791 (2001).
176. Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002; 21: 15-24.
177. Lv F-F, Li N, Zheng L-Q, Tung S-H. Studies on the stability of the chloramphenicol in the microemulsion free of alcohols. Eur J Pharm Biopharm 2006; 62: 288-294.
178. Fialho SL, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Expt Opthal 2004; 32: 626-632.
179. Habe A, Keipert S. Development and characterization of microemulsions for ocular application. Eur J Pharm Biopharm 1997; 43: 179-183.
180. Brodin, A., Fynes, R., Heijl, R., Nyqvist-Mayer, A., Scherlund, M.: US20006031007 (2000).
181. Monahan, S.D., Wolff, J.A., Slattum, P.M., Hagstrom, J.E., Budker, V.G.: US20026429200 (2002).
182. Wheeler, J.J., Bally, M.B.: US5478860 (1995).
183. Maranhao, R.C.: US5578583 (1996).
184. Shiokawa T, Hattori Y, Kawano K, et al. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumour effect in vitro and in vivo. Clin Cancer Res 2005; 11: 2018-2025.
185. Wermling DP, Miller JP, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous and intramuscular administration. J Clin Pharmacol 2001; 41: 1225-1231.
186. Dorman DC, Brenneman KA, McElveen AM, Lynch SE, Roberts KC, Wong BA. Olfactory transport: A direct route of delivery of inhaled managanese phosphate to the rat brain. J Toxicol Environ Health A 2002; 65: 1493-1511.
187. Dragphia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L. Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther Aug 1995; 2: 418-423.
188. Illum L. Transport of drugs from the nasal cavity to central nervous system. Eur J Pharm Sci 2000; 11: 1-18.
189. Talegaonkar S, Mishra P. Intranasal delivery: An approach to bypass the blood brain barrier. Ind J Pharmacol 2004; 36: 140-147.